Leonard Schleifer, Regeneron CEO: $30.047 million
George Yancopoulos, Regeneron R&D chief: $81 million
Robert Coury, Mylan chairman: $28 million
Daniel Vasella, Novartis former chairman: $13.98 million
Questions are continually raised about whether these pay packages reflect the true value of not only the CEOs, CFOs, and executives, but also the cost of legitimate research, development, and true innovation, which does not include me-too drugs and evergreened drugs.
20 Highest-Paid Biopharma CEOs of 2012
Top 10 Biotech CEO Pay Packages of 2012